Clinical Trials Directory

Trials / Unknown

UnknownNCT03206593

Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure

Fasting Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Guangdong Provincial People's Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Current prospective cohort study is to evaluate the association between fasting lipid profiles (including total cholesterol, low density lipoprotein-cholesterol, high density lipoprotein-cholesterol, triglycerides, apolipoprotein A, apolipoprotein B and lipoprotein(a)) and fasting plasma glucose at admission with cardiovascular disease outcomes (including fatal and non-fatal myocardial infarction, fatal and non-fatal ischemic stroke, re-hospitalization due to heart failure, revascularization by percutaneous coronary intervention or coronary artery bypass grafting, or cardiovascular mortality) and all-cause mortality.in patients with ischemic heart failure and left ventricular ejection fraction \< 45 % evaluated by echocardiography during 12 months follow-up.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2018-12-31
Completion
2019-12-31
First posted
2017-07-02
Last updated
2017-07-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03206593. Inclusion in this directory is not an endorsement.